Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.

Gynecologic oncology - 1 May 2016

Backes Floor J, Walker Christopher J, Goodfellow Paul J, Hade Erinn M, Agarwal Garima, Mutch David, Cohn David E, Suarez Adrian A

Abstract excerpt

BACKGROUND: We sought to validate the prognostic significance of estrogen receptor alpha (ERα) expression and to investigate the relationship between ESR1 mutation status and outcomes in a large cohort of patients with endometrial cancer. We also investigated the predictive value of ERα for lymph node involvement in a large surgically staged cohort. METHODS: A tumor microarray (TMA) was constructed including only...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Estrogen Receptor alpha

Share to Lymphatic Metastasis

Share to Neoplasm Grading

Share to Neoplasm Staging

Share to Tissue Array Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 26957478
DOI: 10.1016/j.ygyno.2016.03.006
PMCID: PMC4878441

Genes

ESR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.PMID 26957478Read ↗

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.Semantic proximity Read ↗

ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.Semantic proximity Read ↗

Estrogen Receptor, GATA-3, TTF-1, and KRAS in Endometrial Carcinoma of No Specific Molecular Profile: Prognostic or Diagnostic Markers?Semantic proximity Read ↗

Incidence of ESR1 gene mutations among patients with endometrioid endometrial cancer.Semantic proximity Read ↗

Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study.Semantic proximity Read ↗

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer.Semantic proximity Read ↗

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.Semantic proximity Read ↗

The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen.Semantic proximity Read ↗

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.Semantic proximity Read ↗

ESR1 genetic alterations and their association with clinicopathologic characteristics in advanced breast cancer: a single academic institution experience.Semantic proximity Read ↗

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistrySemantic proximity Read ↗

Estrogen receptor alpha polymorphisms and the risk of malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.